Thailand Diabetes Registry Project: Current status of dyslipidemia in Thai diabetic patients

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 1, 2006, Pages

  Pratipanawatr, Thongchai ^a,l   Rawdaree, Petch ^b   Chetthakul, Thanya ^c   Bunnag, Pongamorn ^d   Ngarmukos, Chardpraorn ^d   Benjasuratwong, Yupin ^e   Leelawatana, Rattana ^f   Kosachunhanun, Natapong ^g   Plengvidhya, Nattachet ^h   Deerochanawong, Chaicharn ⁱ   Suwanwalaikorn, Sompongse ^j   Krittiyawong, Sirinate ^k   Mongkolsomlit, Sirima ^b   Komoltri, Chulaluk ^h  

^a KHON KAEN UNIVERSITY   (Thailand)

^b NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^c Maharat Nakhon Ratchasrima Hospital

^d MAHIDOL UNIVERSITY   (Thailand)

^e Phramongkutklao Hospital   (Thailand)

^f PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^g Faculty of Medicine Chiang Mai University   (Thailand)

^h MAHIDOL UNIVERSITY   (Thailand)

ⁱ RAJAVITHI HOSPITAL   (Thailand)

^j CHULALONGKORN UNIVERSITY   (Thailand)

^k Theptarin General Hospital   (Thailand)

^l KHON KAEN UNIVERSITY   (Thailand)

more..

Author keywords

Diabetes; Diabetes registry; Dyslipidemia; Lipid lowering agents

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANAMNESIS; ARTICLE; CALCULATION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE REGISTRY; DYSLIPIDEMIA; FEMALE; HEALTH CARE PLANNING; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PREVALENCE; SCREENING TEST; SOCIOECONOMICS; TERTIARY HEALTH CARE; THAILAND; UNIVERSITY HOSPITAL;

AGED; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; REGISTRIES; THAILAND;

EID: 33845380362     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-34.
2. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-20.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
4. Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003; 361: 2005-16.
5. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-96.
6. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350: 1495-504.
7. de Lemos JA, Blazing MA, Wiviott SD, Lewis EF, Fox KA, White HD, et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 2004; 292: 1307-16.
8. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004; 291: 1071-80.
9. American Diabetes Association. Standard of medical care in diabetes. Diabetes Care 2005; 28(Suppl 1): S4-36.
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26(Suppl 1): S5-20.
11. Serirat S, Makarasara C, Sunthornthepvarakul T, Deerochanawong C, Phongviratchai S. Lipid disorders in Thai diabetic patients at Rajavithi Hospital. J Med Assoc Thai 1992; 75: 213-6.